» Articles » PMID: 21980375

HF-EPR, Raman, UV/VIS Light Spectroscopic, and DFT Studies of the Ribonucleotide Reductase R2 Tyrosyl Radical from Epstein-Barr Virus

Overview
Journal PLoS One
Date 2011 Oct 8
PMID 21980375
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) belongs to the gamma subfamily of herpes viruses, among the most common pathogenic viruses in humans worldwide. The viral ribonucleotide reductase small subunit (RNR R2) is involved in the biosynthesis of nucleotides, the DNA precursors necessary for viral replication, and is an important drug target for EBV. RNR R2 generates a stable tyrosyl radical required for enzymatic turnover. Here, the electronic and magnetic properties of the tyrosyl radical in EBV R2 have been determined by X-band and high-field/high-frequency electron paramagnetic resonance (EPR) spectroscopy recorded at cryogenic temperatures. The radical exhibits an unusually low g₁-tensor component at 2.0080, indicative of a positive charge in the vicinity of the radical. Consistent with these EPR results a relatively high C-O stretching frequency associated with the phenoxyl radical (at 1508 cm⁻¹) is observed with resonance Raman spectroscopy. In contrast to mouse R2, EBV R2 does not show a deuterium shift in the resonance Raman spectra. Thus, the presence of a water molecule as a hydrogen bond donor moiety could not be identified unequivocally. Theoretical simulations showed that a water molecule placed at a distance of 2.6 Å from the tyrosyl-oxygen does not result in a detectable deuterium shift in the calculated Raman spectra. UV/VIS light spectroscopic studies with metal chelators and tyrosyl radical scavengers are consistent with a more accessible dimetal binding/radical site and a lower affinity for Fe²⁺ in EBV R2 than in Escherichia coli R2. Comparison with previous studies of RNR R2s from mouse, bacteria, and herpes viruses, demonstrates that finely tuned electronic properties of the radical exist within the same RNR R2 Ia class.

Citing Articles

Structure-function mapping and mechanistic insights on the SARS CoV2 Nsp1.

Salgueiro B, Saramago M, Tully M, Arraiano C, Moe E, Matos R Protein Sci. 2024; 33(12):e5228.

PMID: 39584680 PMC: 11586866. DOI: 10.1002/pro.5228.


Identification of the vibrational marker of tyrosine cation radical using ultrafast transient infrared spectroscopy of flavoprotein systems.

Pirisi K, Nag L, Fekete Z, Iuliano J, Tolentino Collado J, Clark I Photochem Photobiol Sci. 2021; 20(3):369-378.

PMID: 33721272 PMC: 8791523. DOI: 10.1007/s43630-021-00024-y.


A tyrosine-tryptophan dyad and radical-based charge transfer in a ribonucleotide reductase-inspired maquette.

Pagba C, McCaslin T, Veglia G, Porcelli F, Yohannan J, Guo Z Nat Commun. 2015; 6:10010.

PMID: 26627888 PMC: 4686667. DOI: 10.1038/ncomms10010.


The class Ib ribonucleotide reductase from Mycobacterium tuberculosis has two active R2F subunits.

Hammerstad M, Rohr A, Andersen N, Graslund A, Hogbom M, Andersson K J Biol Inorg Chem. 2014; 19(6):893-902.

PMID: 24585102 DOI: 10.1007/s00775-014-1121-x.


Use of electron paramagnetic resonance to solve biochemical problems.

Sahu I, McCarrick R, Lorigan G Biochemistry. 2013; 52(35):5967-84.

PMID: 23961941 PMC: 3839053. DOI: 10.1021/bi400834a.


References
1.
Dahlroth S, Lieu V, Haas J, Nordlund P . Screening colonies of pooled ORFeomes (SCOOP): a rapid and efficient strategy for expression screening ORFeomes in Escherichia coli. Protein Expr Purif. 2009; 68(2):121-7. DOI: 10.1016/j.pep.2009.07.010. View

2.
Wnuk S, Robins M . Ribonucleotide reductase inhibitors as anti-herpes agents. Antiviral Res. 2006; 71(2-3):122-6. DOI: 10.1016/j.antiviral.2006.03.002. View

3.
Kashlan O, Scott C, Lear J, Cooperman B . A comprehensive model for the allosteric regulation of mammalian ribonucleotide reductase. Functional consequences of ATP- and dATP-induced oligomerization of the large subunit. Biochemistry. 2002; 41(2):462-74. DOI: 10.1021/bi011653a. View

4.
Rofougaran R, Vodnala M, Hofer A . Enzymatically active mammalian ribonucleotide reductase exists primarily as an alpha6beta2 octamer. J Biol Chem. 2006; 281(38):27705-11. DOI: 10.1074/jbc.M605573200. View

5.
Nyholm S, Mann G, Johansson A, Bergeron R, Graslund A, Thelander L . Role of ribonucleotide reductase in inhibition of mammalian cell growth by potent iron chelators. J Biol Chem. 1993; 268(35):26200-5. View